Skip to main content
AUTOBIO DIAGNOSTICS CO., LTD logo

AUTOBIO DIAGNOSTICS CO., LTD — Investor Relations & Filings

Ticker · 603658 ISIN · CNE100002GC4 LEI · 300300HTZSCUCA32U369 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,291 across all filing types
Latest filing 2019-12-13 AGM Information
Country CN China
Listing Shanghai Stock Exchange 603658

About AUTOBIO DIAGNOSTICS CO., LTD

https://en.autobio.com.cn/

Autobio Diagnostics Co., Ltd. specializes in the research, development, manufacturing, and distribution of comprehensive in vitro diagnostic (IVD) solutions. The company offers an extensive portfolio of products across multiple clinical disciplines, including immunoassay, microbiology, and molecular diagnostics. Key offerings include high-throughput chemiluminescence immunoassay (CLIA) systems, enzyme-linked immunosorbent assay (ELISA) kits, and automated microbiology platforms for blood culture and microbial identification. Autobio also provides integrated laboratory automation systems designed to enhance diagnostic efficiency and accuracy. By focusing on technological innovation and quality, the company serves clinical laboratories, hospitals, and medical institutions worldwide, supporting the detection of infectious diseases, oncology markers, and various metabolic disorders.

Recent filings

Filing Released Lang Actions
2019年第二次临时股东大会文件
AGM Information Classification · 95% confidence The document is titled as the "2019 Second Extraordinary General Meeting (EGM) Meeting Documents" of Autobio Diagnostics Co., Ltd. It contains detailed agenda, meeting procedures, voting instructions, and a specific proposal regarding a related-party loan transaction. The content is focused on the meeting materials for a shareholders' meeting rather than a report or announcement of results. The document length is 4147 characters, which is relatively short and consistent with meeting materials rather than a full report. There is no financial statement or earnings data presented, nor is it a transcript or presentation. The document is clearly the meeting materials for an Extraordinary General Meeting (EGM), which falls under the category of AGM Information (AGM-R) as it includes the agenda, proposals, and procedural details for the shareholders' meeting.
2019-12-13 Chinese
关于控股股东拟发行可交换债券对持有的部分本公司A股股票办理担保及信托登记的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by Zhengzhou Antu Biological Engineering Co., Ltd. regarding the controlling shareholder's plan to issue exchangeable bonds secured by a portion of the company's A shares. It details the guarantee and trust registration related to the bond issuance, including the trustee and the securities involved. The document is relatively short (893 characters) and focuses on a financing activity involving bond issuance and share collateral. It does not contain financial statements or detailed financial performance data, nor is it a report or transcript. This fits the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities.
2019-12-10 Chinese
关于控股子公司取得医疗器械注册证书的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the receipt of a medical device registration certificate by a controlling subsidiary. It includes details about the certificate, product information, R&D investment, market context, and potential impact on company performance. The document is short (943 characters) and does not contain financial statements or detailed financial data. It is an announcement of a regulatory or operational milestone rather than a financial report or management discussion. It does not fit categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is not a regulatory filing in the sense of compliance or officer certification, but rather a specific operational announcement. Given the available categories, the best fit is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory announcements that do not fit other categories.
2019-12-10 Chinese
关于召开2019年第二次临时股东大会的通知
Regulatory Filings Classification · 95% confidence The document is a notice about convening the 2019 second extraordinary general meeting of shareholders for Zhengzhou Antu Bioengineering Co., Ltd. It includes details about the meeting date, voting methods, agenda items, and instructions for shareholders. It does not contain financial statements or detailed financial performance data. It is an announcement related to a shareholders' meeting rather than the meeting materials or results themselves. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or possibly Proxy Solicitation & Information Statement (PSI). However, since it is a notice of the meeting and voting procedures rather than solicitation materials, it is best classified as a Regulatory Filing (RNS) as a fallback for general regulatory announcements that do not fit other categories. The document length is under 5,000 characters and is a formal announcement of the meeting, not the report or results themselves.
2019-12-06 Chinese
第三届董事会第十次会议决议公告
Board/Management Information Classification · 100% confidence The document is a formal announcement of the resolutions passed at the 10th meeting of the 3rd Board of Directors of Zhengzhou Antu Biological Engineering Co., Ltd. It details the meeting attendance, voting results, and mentions related announcements on the stock exchange website. The content focuses on board meeting decisions, including approval of related party transactions and calling an extraordinary shareholders meeting. There is no financial data, earnings information, or detailed report content. The document is clearly about board/management information, specifically board meeting resolutions and related disclosures. Therefore, the appropriate classification is 'Board/Management Information' (MANG). The document length and content confirm it is not a full report or announcement of a report publication but a board meeting resolution announcement.
2019-12-06 Chinese
关于向控股股东借款暨关联交易的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding a related party transaction where the company's controlling shareholder provides a loan to the company and its subsidiaries. It details the loan amount, terms, related party relationship, pricing policy, and the approval process including board and shareholder meetings. The document is relatively short (2011 characters) and focuses on the announcement of a financing transaction involving related parties. It does not contain financial statements or detailed financial performance data. This fits the definition of a Capital/Financing Update (CAP) as it updates on company financing activities and capital structure changes involving related party loans.
2019-12-06 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.